Position in ARVN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$115,752
-$60,096 QoQ
Shares Held
10,920
-26.4% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in ARVN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $115,752 | 10,920 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $175,848 | 14,827 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $117,865 | 13,834 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $119,077 | 16,179 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $119,403 | 17,009 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $409,260 | 21,349 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $398,907 | 16,196 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $292,287 | 10,980 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $570,984 | 13,832 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $479,267 | 11,644 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $244,278 | 9,842 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $257,299 | 9,418 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $364,712 | 10,661 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $437,692 | 9,838 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $404,274 | 9,605 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $964,072 | 14,325 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,457,245 | 17,741 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,323,180 | 16,101 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,549,625 | 20,125 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,073,794 | 16,245 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,181,291 | 13,909 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $233,715 | 9,899 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $343,114 | 10,230 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $266,463 | 6,612 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||